SpiceJet Offers Extra Legroom to Passengers
Chennai: With a view to enhance convenience for passengers, SpiceJet, India's second largest low fare airline, has announced introduction of 'SpiceMax', a scheme that offers more leg room for little more money from August 15.
SpiceJet customers opting for 'SpiceMax' seats will enjoy best in class legroom with at least 6 inches more legroom to relax compared to standard seats and with priority check-in at dedicated SpiceMax counters at major airports.
'SpiceMax' is designed for customers who want more comfort and convenience but are not willing to pay the huge premium for business class, the airline said.
"SpiceMax seats are available on our domestic and international sectors operated by the modified aircrafts on a first come first served basis," as per the carrier's website.
SpiceJet has reconfigured most of its Boeing 737 fleet such that the first five rows now have this extra legroom, along with the exit row seats that have more legroom, the airline said in a release in Chennai.
The Boeing 737 fleet will have 30 SpiceMAX seats (first five rows), whereas the Bombardier Q400 fleet will remain with 4 SpiceMAX seats (first row).
"We have repeatedly heard from many of our customers, including our corporate customers, that while they are not always willing to pay the huge premium for Business Class, they would be happy to pay a little more for greater comfort and convenience in economy class so that they have more personal space, legroom, and greater freedom to work and relax during their frequent travels," SpiceJet chief operating officer Sanjiv Kapoor said.
For a limited time, the SpiceMax product can be purchased at a promotional offer starting at Rs 500 per seat over and above the ticket price.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.